Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04666844
Other study ID # SIH126_PD Suprise Question
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 20, 2020
Est. completion date July 20, 2022

Study information

Verified date July 2022
Source Satellite Healthcare
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The investigators will assess the prediction performance of the modified Surprise Question (Will the participant be surprised if this patient transfers to hemodialysis in the next 6 months?) for identification of peritoneal dialysis at high risk of transfer to hemodialysis. The investigators will also assess the prediction performance of a modified mortality surprise question (Will the participant be surprised if this patient dies in the next 6 months?).


Description:

Physicians and nurses will be asked two questions regarding each of their peritoneal dialysis patients: 1. Will the participant be surprised if this patient transfers to hemodialysis in the next 6 months? 2. Will the participant be surprised if this patient dies in the next 6 months? Patients will be followed for 6 months for outcomes (with two extra months for ascertainment of outcomes).


Recruitment information / eligibility

Status Completed
Enrollment 2019
Est. completion date July 20, 2022
Est. primary completion date May 30, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Patients: Inclusion Criteria: - Incident and prevalent PD population at Satellite Healthcare Exclusion Criteria: - Age < 18 years - Patients already enrolled in hospice - Patients on PD training - Patients on backup hemodialysis

Study Design


Related Conditions & MeSH terms


Intervention

Other:
no intervention
Observational Study

Locations

Country Name City State
United States Satellite Healthcare Inc San Jose California

Sponsors (1)

Lead Sponsor Collaborator
Satellite Healthcare

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Performance measures of the modified surprise question answered by the physicians as a prediction instrument for transfer to hemodialysis of peritoneal dialysis patients in 6 months. at 6 months
Secondary Performance measures of the modified SQ Responses of the nurses to predict Transfers to hemodialysis at 6 months
Secondary Performance measures of the mortality SQ Responses of the physician and nurses to predict death at 6 months
Secondary Performance of prediction model for transfer to HD developed from variables obtained at baseline. at 0 months
Secondary Comparison of performance of baseline variables model to performance of the SQ model, and to a model that combines baseline variables and the SQ. at 6 month
Secondary Rate of hospitalizations in patients identified as high risk by the surprise question. at 6 months
Secondary Rate of peritonitis in patients identified as high risk by the surprise question. at 6 months
Secondary Proportion of patients identified as high risk who transition to HD. At time of transfer to hemodialysis, for those who transfer to hemodialysis within the observation period, which is 6 months from response to the surprise question
Secondary Proportion of patients who transition to HD who (i) start Home HD and those who (ii) start HD with AVF/AVG - in the whole group and among those identified high or low risk by the surprise question. At time of transfer to hemodialysis, for those who transfer to hemodialysis within the observation period, which is 6 months from response to the surprise question
Secondary Evaluating the agreement of assessments made by the primary nephrologist and the primary nurse of the patient at baseline
Secondary Factors associated with predictions made by the MD and nurse. at baseline
See also
  Status Clinical Trial Phase
Not yet recruiting NCT04925674 - Study of HEC53856 in Patients With Subjects With End-Stage Renal Disease Receiving Dialysis. Phase 1
Terminated NCT03438877 - Intensive Versus Regular Dosage For PD In AKI. N/A
Completed NCT05149508 - Intraperitoneal Pressure Measurements in Children
Not yet recruiting NCT04900610 - The Effect of Vitamin K2 Supplementation on Arterial Stifness and Cardiovascular Events in PEritonial DIAlysis N/A
Withdrawn NCT03019159 - Assessment of a Follow-up With Tele-consulting for Patients With Renal Failure Under Peritoneal Dialysis N/A
Recruiting NCT01195519 - The Assessment of Quality of Life in Patients With Peritoneal Dialysis and Hemodialysis N/A
Recruiting NCT06351007 - Educational Program on Dietary Adherence and Nutritional Knowledge in Chronic Kidney Disease Patients (EPAK) N/A
Not yet recruiting NCT04628117 - Effect of Oral Nutritional Supplementation on Oxidative Stress in Protein-energy Wasting Patients With Peritoneal Dialysis N/A
Recruiting NCT05449067 - CAPD Versus APD in Nondiabetic Peritoneal Dialysis Patients N/A
Not yet recruiting NCT03953950 - Effect of Add-on Spironolactone to Losartan Versus Losartan Alone on Peritoneal Membrane Among Peritoneal Dialysis Patients Phase 4
Completed NCT02128347 - Effectiveness of an Online Portal for Delivery of Care to Home Dialysis Patients N/A
Completed NCT01209273 - Comparison of Quality of Life on Automated Peritoneal Dialysis and Continuous Ambulatory Peritoneal Dialysis N/A
Completed NCT00734552 - Study to Evaluate the Protective Effect of α-Keto Acid With Low-protein Diet on Renal Function in PD Patients N/A
Not yet recruiting NCT06096558 - The Effects of Melatonin on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients N/A
Completed NCT04413266 - Effects of Curcumin Supplementation in Patients With Chronic Kidney Disease on Peritoneal Dialysis N/A
Not yet recruiting NCT06060951 - Relating Abdominal Complications With Peritoneal Pressure Estimation and Reporting
Completed NCT03980795 - Exercise in Peritoneal Dialysis Patients (PDEX) N/A
Not yet recruiting NCT02270229 - Evaluation of the Peritoneal Dialysis Program in a Hospital in Chinandega, Nicaragua. N/A
Completed NCT02347592 - Peritoneal Dialysis Catheter Function N/A
Withdrawn NCT00397358 - Effect of Extraneal (Icodextrin)on Triglyceride Levels in PD Patients Phase 4